19-17606350-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2
The NM_001080421.3(UNC13A):āc.4816C>Gā(p.Leu1606Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,543,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080421.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC13A | NM_001080421.3 | c.4816C>G | p.Leu1606Val | missense_variant | 44/44 | ENST00000519716.7 | NP_001073890.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UNC13A | ENST00000519716.7 | c.4816C>G | p.Leu1606Val | missense_variant | 44/44 | 5 | NM_001080421.3 | ENSP00000429562 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000146 AC: 2AN: 136980Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 74586
GnomAD4 exome AF: 0.0000259 AC: 36AN: 1391534Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 17AN XY: 686732
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2024 | The c.4816C>G (p.L1606V) alteration is located in exon 44 (coding exon 44) of the UNC13A gene. This alteration results from a C to G substitution at nucleotide position 4816, causing the leucine (L) at amino acid position 1606 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at